Develops novel enhancements to existing orthopaedic medical devices.
Stabiliz Orthopaedics was named one of the most promising Life Science companies at the 8th Annual Rice Alliance for Technology & Entrepreneurship Life Science Venture Forum in Houston, Texas, where life science companies showcased their new ventures for an audience of more than 400 attendees, including investors, venture capitalists, industry representatives, business leaders, advisors/mentors, service providers, and entrepreneurs. Stabiliz Orthopaedics was formed by Drexel University’s LeBow College of Business LEAD MBA students, Doug Cerynik M.D, Bradley S. Grossman, Michael Adelizzi and Mark Seltzer. The company was formed to develop novel enhancements to existing orthopaedic medical devices utilizing innovative concepts, providing a quick path to market. With its initial products under patent protection, Stabiliz Orthopaedics aims to foster greater clinical outcomes for traumatic fracture patients, ultimately reducing additional health care-related costs.